Author
Listed:
- Can Liu
(University of Texas MD Anderson Cancer Center
Cancer Stem Cell Institute, Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine)
- Ruifang Liu
(University of Texas MD Anderson Cancer Center
Cancer Stem Cell Institute, Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine
Roswell Park Cancer Institute)
- Dingxiao Zhang
(University of Texas MD Anderson Cancer Center
Roswell Park Cancer Institute)
- Qu Deng
(University of Texas MD Anderson Cancer Center
Roswell Park Cancer Institute
Program in Molecular Carcinogenesis, University of Texas Graduate School of Biomedical Sciences (GSBS))
- Bigang Liu
(University of Texas MD Anderson Cancer Center)
- Hsueh-Ping Chao
(University of Texas MD Anderson Cancer Center
Program in Molecular Carcinogenesis, University of Texas Graduate School of Biomedical Sciences (GSBS))
- Kiera Rycaj
(University of Texas MD Anderson Cancer Center
Roswell Park Cancer Institute)
- Yoko Takata
(University of Texas MD Anderson Cancer Center)
- Kevin Lin
(University of Texas MD Anderson Cancer Center)
- Yue Lu
(University of Texas MD Anderson Cancer Center)
- Yi Zhong
(University of Texas MD Anderson Cancer Center)
- John Krolewski
(Roswell Park Cancer Institute)
- Jianjun Shen
(University of Texas MD Anderson Cancer Center)
- Dean G. Tang
(University of Texas MD Anderson Cancer Center
Cancer Stem Cell Institute, Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine
Roswell Park Cancer Institute)
Abstract
MicroRNAs play important roles in regulating tumour development, progression and metastasis. Here we show that one of the miR-200 family members, miR-141, is under-expressed in several prostate cancer (PCa) stem/progenitor cell populations in both xenograft and primary patient tumours. Enforced expression of miR-141 in CD44+ and bulk PCa cells inhibits cancer stem cell properties including holoclone and sphere formation, as well as invasion, and suppresses tumour regeneration and metastasis. Moreover, miR-141 expression enforces a strong epithelial phenotype with a partial loss of mesenchymal phenotype. Whole-genome RNA sequencing uncovers novel miR-141-regulated molecular targets in PCa cells including the Rho GTPase family members (for example, CDC42, CDC42EP3, RAC1 and ARPC5) and stem cell molecules CD44 and EZH2, all of which are validated as direct and functionally relevant targets of miR-141. Our results suggest that miR-141 employs multiple mechanisms to obstruct tumour growth and metastasis.
Suggested Citation
Can Liu & Ruifang Liu & Dingxiao Zhang & Qu Deng & Bigang Liu & Hsueh-Ping Chao & Kiera Rycaj & Yoko Takata & Kevin Lin & Yue Lu & Yi Zhong & John Krolewski & Jianjun Shen & Dean G. Tang, 2017.
"MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes,"
Nature Communications, Nature, vol. 8(1), pages 1-14, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14270
DOI: 10.1038/ncomms14270
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14270. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.